VYGR - Voyager Therapeutics, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5778.99M
Enterprise Value 3521.32M
Trailing P/E N/A
Forward P/E 1-8.61
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)102.24
Price/Book (mrq)14.75
Enterprise Value/Revenue 368.42
Enterprise Value/EBITDA 6-5.86

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Dec 31, 2018


Profit Margin 0.00%
Operating Margin (ttm)-1,195.63%

Management Effectiveness

Return on Assets (ttm)-31.50%
Return on Equity (ttm)-97.83%

Income Statement

Revenue (ttm)7.62M
Revenue Per Share (ttm)0.24
Quarterly Revenue Growth (yoy)-68.40%
Gross Profit (ttm)-57.29M
EBITDA -88.98M
Net Income Avi to Common (ttm)-88.29M
Diluted EPS (ttm)-2.75
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)155.81M
Total Cash Per Share (mrq)4.78
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)5.13
Book Value Per Share (mrq)1.43

Cash Flow Statement

Operating Cash Flow (ttm)-15.89M
Levered Free Cash Flow (ttm)-31.57M

Trading Information

Stock Price History

Beta (3Y Monthly) 2.50
52-Week Change 317.70%
S&P500 52-Week Change 310.91%
52 Week High 324.24
52 Week Low 37.76
50-Day Moving Average 319.41
200-Day Moving Average 313.72

Share Statistics

Avg Vol (3 month) 3604.46k
Avg Vol (10 day) 3335.26k
Shares Outstanding 536.8M
Float 17.65M
% Held by Insiders 16.28%
% Held by Institutions 10.00%
Shares Short (Mar 29, 2019) 41.86M
Short Ratio (Mar 29, 2019) 42.95
Short % of Float (Mar 29, 2019) 410.08%
Short % of Shares Outstanding (Mar 29, 2019) 45.05%
Shares Short (prior month Feb 28, 2019) 41.31M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A